Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Labomascus
P2.01-61 Body Mass Index Over Time Is Associated With Overall Survival in Advanced NSCLC Patients Treated With Immunotherapy.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Circulating microRNAs and PD-L1 Tumor Expression Are Associated With Survival in Advanced NSCLC Patients Treated With Immunotherapy: A Prospective Study
Clinical Cancer Research
Cancer Research
Oncology
Association Between Baseline Body Mass Index and Overall Survival Among Patients Over Age 60 With Acute Myeloid Leukemia
American Journal of Hematology
Hematology
Increased Body Mass Index Is Associated With Improved Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Oncotarget
Oncology
MA10.05 Effect of Early Steroids Use in Advanced NSCLC Patients Treated With Immunotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Exercise Restriction Is Not Associated With Increasing Body Mass Index Over Time in Patients With Anomalous Aortic Origin of the Coronary Arteries
Cardiology in the Young
Pediatrics
Cardiology
Perinatology
Cardiovascular Medicine
Medicine
Child Health
Association of Systemic Inflammation Index and Body Mass Index With Survival in Patients With Renal Cell Cancer Treated With Nivolumab
Clinical Cancer Research
Cancer Research
Oncology
Predictive Factors Associated With Prolonged Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated With Gefitinib
British Journal of Cancer
Cancer Research
Oncology
P2.01-88 C-Reactive Protein (CRP) as a Predictive Marker for Survival in Patients With Advanced NSCLC Treated With First Line Pembrolizumab Monotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Table S11: 61 DEmRNAs Associated With Overall Survival in Endometrial Carcinoma
